IndraLab

Statements

HDAC inhibits BAP1. 4 / 4
| 4
reach
"Histone deacetylase (HDAC) inhibitors have been shown to reverse the phenotypic effects of BAP1 loss by inducing morphologic differentiation and transition from a high-risk to a low-risk gene expression profile in uveal melanoma cells."
29497459
reach
"We then investigated whether HDAC inhibition could reverse the phenotypic consequences of BAP1 loss : loss of melanocytic differentiation and acquisition of the class 2 gene expression profile."
22038994
reach
"Histone deacetylase (HDAC) inhibitors, such as the readily available valproic acid, can reverse this effect of BAP1 loss and may play a role in treated patients with high-risk class 2 uveal melanomas in an adjuvant setting prior to the emergence of overt metastatic disease [XREF_BIBR]."
24713608
reach
"Pharmacologic inhibition of histone deacetylase activity rescues Bap1-deficient gastrulation phenotype."
31555735